| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Drutz David is a Director at ALT. Recent filings cover 6 purchases and 2 sales. Those positions are worth an estimated $385K at current prices.
Our model assigns Drutz David a middling insider score of 65/100, based on 5 past trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +38.4%.
Drutz David's largest disclosed position is in ALT as Director, worth about $385K. Net of sales, the recent Form 4 record there shows accumulation of 5,489 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | ALT Altimmune, Inc. | Director | Sale+OE | 16,011 | $6.90 | $110,547.03 | -22.4% | -5.2% | -52.0% | |
| Aug 15, 2023 | ALT Altimmune, Inc. | Director | Buy | 300 | $2.88 | $862.50 | +1.0% | -13.2% | +119.9% | |
| Mar 23, 2023 | ALT Altimmune, Inc. | Director | Buy | 9,000 | $4.27 | $38,430.00 | +43.9% | 0.0% | +116.7% | |
| Jun 15, 2022 | ALT Altimmune, Inc. | Director | Buy | 1,000 | $8.00 | $8,000.00 | +5.3% | +145.0% | -50.8% | |
| May 24, 2022 | ALT Altimmune, Inc. | Director | Buy | 1,200 | $4.50 | $5,400.00 | +6.7% | +275.0% | -9.1% | |
| Aug 23, 2017 | ALT Altimmune, Inc. | Director | Buy | 10,000 | $2.21 | $22,097.00 | +48.1% | - | - |